XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development expenses $ 3,830 $ 6,991
Selling, general and administrative expenses 24,468 21,635
Total operating expense 28,298 28,626
Operating loss (28,298) (28,626)
Investment and other income (expense), net 193 (104)
Interest expense (3,259) (2,017)
Loss before income taxes (31,364) (30,747)
Income tax benefit (580) (4,323)
Net loss $ (30,784) $ (26,424)
Net loss per share - basic (in dollars per share) $ (0.48) $ (0.45)
Net loss per share - diluted (in dollars per share) $ (0.48) $ (0.45)
Weighted average number of shares outstanding - basic (in shares) 63,886 58,824
Weighted average number of shares outstanding - diluted (in shares) 63,886 58,824